To describe the latest evidence for methicillin-resistant Staphylococcus aureus (MRSA) infection control strategies, with particular emphasis on active surveillance cultures with contact precautions and targeted decolonization, and their impact.
INTRODUCTION
Since its discovery in 1961 [1] , methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a major cause of healthcare-associated infections globally with significant morbidity and mortality [2,3 & ]. Admittedly, copious amounts of studies, position papers and guidelines have been published over the years towards controlling MRSA, precipitating a declining trend globally [4] . The last couple of years have been exciting and interesting with top researchers publishing high-quality studies on prevention and control of multidrug-resistant organisms (MDROs), especially MRSA (Table 1) . These meticulously designed studies took on the monumental task of assessing effectiveness of different measures in controlling MRSA of both horizontal interventions such as hand hygiene and universal decolonization, as well as vertical interventions such as screening and contact isolation ( Fig. 1) .
MRSA screening and contact isolation strategy's primary aim is to prevent transmission of MRSA from carriers to noncarriers. Even though this may not necessarily prevent infection in colonized patients, a reduction in new MRSA carriers could produce a net reduction in infections [10 MDROs. Although some experts argue that decolonization should be the only strategy, others contend that it should be a supplement to screening and contact isolation [7 && ,12] . A recent editorial in the New England Journal of Medicine (NEJM) [13] suggested closing all doors on screening and contact precautions as a viable strategy for control of MRSA.
In this review, we aim to analyse recent studies published on control of MRSA to decide whether MRSA screening and contact isolation remains a viable strategy or whether it has reached the end of the road.
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS CONTROL IN ICUS
Bloodstream infections (BSIs) related to multidrugresistant or extensively drug-resistant organisms are common in ICUs and are associated with a high mortality [14] . Consequently, prevention of acquisition and infection with these pathogens are of paramount importance. MRSA has been studied extensively in this respect, with arguments mounting from both sides of the aisle on value of universal decolonization with or without active surveillance cultures and contact precautions [15] . The main argument for universal admission screening and contact precautions was presented by Jain et al. [16] in the NEJM, when the authors showed an impressive 62% reduction in ICU-related MRSA infections with the implementation of universal surveillance cultures, contact precautions, enhanced hand hygiene and institutional culture change. However, relative importance of the components of the bundle was not assessed. A post-hoc analysis of this study posited that hand hygiene was the single most important factor [17] . Interestingly, in the same issue of NEJM, Huskins et al. [18] published the results of their cluster-randomized trial comparing universal admission screening with contact precautions for MRSA and vancomycin-resistant Enterococci (VRE) colonization against current standard practices (i.e., absence of such interventions) which failed to show significant decrease in MRSA and VRE rates. Both studies drew flak from opponents and proponents of universal screening, and a consensus emerged that more cluster-randomized trials were needed before any practice-changing measures could be adopted on a wide scale.
In February 2013, a multicentre cluster-crossover trial was published by Climo et al. [5 & ] in NEJM in which investigators compared the effectiveness of 2% chlorhexidine-impregnated washcloths against nonantimicrobial washcloths in reducing acquisition of and bacteraemia from MDROs, especially MRSA and VRE, although maintaining active surveillance cultures and contact precautions for VRE and MRSA. Nine ICUs and bone marrow transplant units from seven hospitals, most with MRSA prevalence above 10%, enrolled more than 7000 patients. Hospital-acquired BSI was 28% lower with chlorhexidine bathing with 4.78 cases per 1000 patient-days versus 6.60 cases per 1000 patient-days with nonantimicrobial washcloths. However, it should be noted that the reduction in bacteraemia was contributed mainly by reduction in coagulase-negative S. aureus, and it failed to reduce MRSA acquisition. Furthermore, several letters raised methodological concerns about this study [19] . Milstone et al. [6 && ], in a cluster-randomized crossover trial (SCRUB trial) of paediatric ICUs involving more than 4900 patients, studied the effect of daily bathing with 2% chlorhexidine-impregnated cloth against routine bathing practices without screening for MDROs in either group. The chlorhexidine treatment group showed, in per protocol analysis, an impressive 36% reduction in BSI mostly due to skin commensals. Although the finding was not corroborated by an intention to treat analysis, this study is significant in being one of the first cluster-randomized trials to assess the effect of universal decolonization in paediatric patients.
Although hand hygiene compliance from 52% during Phase 1 to 69% during Phase 2. Interestingly, with hand hygiene compliance rate increasing to 77% in Phase 3, the study did not note any additional benefit after introduction of screening and isolation. Although they were unable to decouple the effect of hand hygiene enhancement from universal skin decolonization (without nasal mupirocin application), this probably was the first cluster-randomized study to methodically confirm the positive role of increased hand hygiene compliance in prevention of MDRO transmission in ICUs.
Huang et al.
[7 && ] 'took the bull by the horns' in their REDUCE-MRSA trial published in NEJM. In this pragmatic cluster-randomized trial involving 74 ICUs from 43 hospitals, investigators compared active surveillance and contact precautions (Group 1); active surveillance, contact precautions and targeted decolonization (Group 2) and universal decolonization regardless of MRSA status (Group 3). MRSA rates ranged between 10.0 and 11.5% between the three groups during a baseline period of 12 months. The 18-month study concluded that universal decolonization showed greater reduction in the hazard of MRSA-positive clinical cultures than did screening and isolation (hazard ratio in Group 3, 0.63; 95% CI, 0.52-0.75; hazard ratio in Group 1, 0.92; 95% CI, 0.77-1.10; P ¼ 0.003). The ICUattributable BSI due to any pathogen was significantly lower in Group 3 with number of decolonization needed to prevent one BSI being 54. However, the reduction was mostly due to skin commensals as seen in other decolonization studies, and it did not demonstrate a significant reduction in ICU-attributable MRSA BSI. This study was done at centres in which universal screening and isolation had already been in place for more than 30 months resulting in an unfair comparison with newly implemented universal decolonization strategies [20, 21] . Hence, a fourth comparison group with universal screening and isolation as a novel strategy would have been informative. Having said that, these data suggest that decolonization (whether universal or targeted) can provide at least an incremental benefit in controlling MRSA cross-infections in ICUs. Although this study cemented universal decolonization strategy's position in discussions around MRSA control in ICUs, it falls short of obviating screening and isolation strategy at the present moment [13] . Furthermore, this approach may increase the clinical impact of mupirocin resistance, as previously observed [22] .
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS CONTROL OUTSIDE INTENSIVE CARE UNITS
MRSA poses continued challenge for surgical patients with limited evidence-based preventive measures [23] . Randomized control trials in the past have failed to show unequivocal benefit of nasal decolonization with mupirocin or chlorhexidine in reducing S. aureus surgical site infections (SSI) although some benefit was seen in reducing nosocomial S. aureus infection [24] . A recent metaanalysis evaluated 16 clinical trials involving 9980 patients and concluded against whole-body chlorhexidine bathing [25] . However, in a systematic review published in the British Medical Journal (BMJ), Schweizer et al. [26 & ] conducted a pooled analysis comparing seven studies which used bundled intervention with nasal decolonization and glycopeptide prophylaxis, 37 studies which implemented nasal decolonization and 15 studies investigating glycopeptide prophylaxis only. They concluded that although nasal decolonization and glycopeptide prophylaxis protected against S. aureus and MRSA SSI respectively, the bundled intervention reduced SSI due to all Gram-positive bacteria, but stressed on the need for randomized control trials to confirm these findings.
These strategies and their interaction with horizontal interventions were investigated by another MOSAR study group. Lee et al. [8 && ] in their controlled trial compared enhanced hand hygiene against universal MRSA screening with contact precautions and targeted decolonization (intranasal mupirocin and chlorhexidine bathing) of MRSA carriers in 33 surgical wards of 10 hospitals in Europe. Interestingly, an unplanned third arm in the study employed a combination of enhanced hand hygiene, targeted MRSA screening based on risk factors, contact precaution and decolonization as per physician preference, thus replicating real-life situations. This combined intervention arm, with a baseline MRSA rate of less than 2.1%, experienced an increase in hand hygiene compliance from 49.3% (95% CI 47.2-51.4%) to 63.8% (95% CI 63.2-64.4%) from baseline to intervention phases. During the intervention phase, 22.3% were screened for MRSA, 35.9% were decolonized and compliance to contact precautions exceeded 90%. This strategy produced a significant reduction in the rate of MRSA-positive clinical cultures of 12% per month (adjusted incidence rate ratios of 0.88; 95% CI 0.79-0.98). A significant reduction of MRSA rates was also observed amongst patients undergoing clean surgery in the study group ascertained to universal MRSA screening with contact precautions and decolonization. The authors logically concluded that a strategy for effective control of MRSA in low-prevalence settings should be multimodal with a combination of horizontal and vertical interventions, with the exception of elective clean surgery in which universal screening and targeted decolonization could be applied successfully, in contrast to the previously cited claim in the editorial by Wenzel et al. [13] .
COSTS AND CONSEQUENCES
Patients on isolation and contact precautions, be it cohort wards, single rooms or shared rooms, receive less attention from healthcare workers. In a retrospective study in 2003, Stelfox et al. [27] showed that patients isolated for infection control precautions suffered from more preventable adverse events and were dissatisfied with their treatment. This purported disadvantage of screening and isolation policy was called into question in 2013 when Harris et al. [28 & ] demonstrated, as a secondary outcome, no significant difference in preventable and unpreventable adverse events between the two study groups in a large cluster-randomized trial. Increased awareness amongst healthcare providers and advances in patient safety monitoring systems available now compared to 10 years ago might be possible explanations for the difference, but further controlled studies are needed to verify these findings.
Another disadvantage of screening and isolation policy is the lack of an evidence-based end point as the duration of colonization with MRSA varies, influenced by various factors including age, race, number of colonizing body sites, skin integrity, decolonization treatment, antibiotics exposure and frequency of contact with the healthcare system [29, 30] . In one study, about 50% of patients were cleared of MRSA at 1 year and close to 80% were MRSA-free at 4 years [31] ; however, high-quality evidence and standardized criteria for discontinuation of contact precautions are lacking. Shenoy et al. [32] documented that in a setting with an MRSA prevalence of 8%, a single nasal PCR performs well against three nasal swab cultures for identifying MRSA carriers with positive and negative predictive values of 86.1 and 96.6%, respectively. Although this study did not address the clinical effectiveness of discontinuation of MRSA contact precautions, it supports the use of a single nasal PCR for identifying MRSA-negative patients because of its rapidity, simplicity and efficiency despite a higher capital and per-test cost.
Decolonization involves applications of topical antibiotics to anterior nares and bathing with an antiseptic solution usually with mupirocin and chlorhexidine. Chlorhexidine has been in clinical use for more than 5 decades and is generally considered the choice biocide for skin decontamination because of its broad spectrum of activity, acceptable tolerability and residual antibacterial activity. Unfortunately, as with all antimicrobials, reports of phenotypic and genotypic resistance to chlorhexidine have been on the rise following its increased usage [33, 34] . MRSA strains carrying qac A/B resistant genes are not only protected from bactericidal activity of chlorhexidine, but could potentially spread more rapidly [35] . In a recent study, investigators showed that the presence of these genes in combination with low-level mupirocin resistance is an independent risk factor for persistence of MRSA carriage after decolonization [22] . Prevalence of mupirocin-resistant MRSA has mirrored the increase and decrease in mupirocin consumption, suggesting an association between the two [36] [37] [38] .
A research gap in good quality empirical studies dedicated to assess the economic impact of MRSA control strategies has resulted in diverse national policies and local strategies. A recent dynamic transmission modelling study in an ICU population concluded that universal decolonization with chlorhexidine had about 70% chance of being the most cost-effective approach, and if universal decolonization is not an acceptable strategy in a centre then universal MRSA PCR screening of all patients with targeted decolonization was the next best alternative [39] . This outcome was persistent regardless of the size of ICU, prevalence of MRSA on admission and proportion of high-risk patients admitted. Outside the ICUs, universal or targeted screening and isolation are widely used to control MRSA. Cost effectiveness of these strategies, alone or in various combinations, is rather murky with modelling studies showing conflicting results [40] [41] [42] [43] [44] . A systematic review of 36 studies published between 1987 and 2011 showed that savings from infection control initiatives aimed at preventing MRSA transmission was approximately seven times higher than their cost [45] . The benefits seen were more pronounced in the intermediate (1-10%) and high (>10%) MRSA prevalence settings. However, this review was not powered to compare the efficacy of targeted versus universal screening.
CONCLUSION
Several recent high-quality studies are endorsing the idea of universal decolonization with or without screening and isolation of MRSA carriers for critically ill ICU patients; however, careful monitoring of mupirocin and chlorhexidine resistance is warranted. Screening and targeted decolonization of MRSA is an acceptable strategy to prevent infection in clean surgery patients. Screening and isolation remains a suitable measure for a hospital-wide MRSA control strategy, especially at centres with moderate to high MRSA rates and low hand hygiene compliance. Even as the doors to ICU begin to close, MRSA screening, targeted decolonization and isolation remains a welcome strategy in specific nonICU settings. . This combined interrupted time-series and cluster-randomized trial showed that a combination of hand hygiene enhancement and universal decolonization is effective in reducing MRSA acquisition, and no additional benefit is gained from universal screening and contact precautions. 10.
